Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On January 15, 2020, the Compensation and Management Development Committee of
the Board of Directors of Syneos Health, Inc. (the "Company") approved entering
into an Executive Service Agreement Amendment (the "Amendment") with Alistair
Macdonald, the Chief Executive Officer of the Company. Pursuant to the
Amendment, Mr. Macdonald's Executive Service Agreement was amended to provide
that, if Mr. Macdonald's employment is terminated without cause or he resigns
for good reason, then he will receive a cash severance payment equal to two
times (or three times if such termination occurs during the period commencing
three months prior to and ending 24 months after a change in control of the
Company) the sum of (i) his base salary plus (ii) his annual target bonus for
the year of termination. Additionally, Mr. Macdonald will be entitled to 36
months of health care coverage continuation.
The foregoing summary of the Amendment is qualified in its entirety by reference
to the full text of the Form of the Amendment, which is filed as Exhibit 10.1 to
this Form 8-K, and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
Exhibit 10.1 Form of Amendment No. 2 to Executive Service Agreement between
Alistair Macdonald and INC Research Holding Limited, dated
January 15, 2020.
Exhibit 104 Cover Page Interactive Data File - the cover page XBRL tags are
embedded within the Inline XBRL document
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses